BD BBL™ MGIT™ PANTA™ Antibiotic Mixture 245114Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 30382902451144), received between Feb 4, 2021 and Feb 4, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Incorrect, Inadequate or Imprecise Result or Readings” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• MalfunctionFeb 4, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings

  IT WAS REPORTED THAT PRIOR TO USE WITH BD BBL¿ MGIT¿ PANTA¿ ANTIBIOTIC MIXTURE, LYOPHILIZED FUNGAL CONTAMINATION WAS DISCOVERED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: THE TB LAB STAFF WENT TO RECONSTITUTE A VIAL OF PANTA LOT 0149921 WITH THE GROWTH SUPPLEMENT LOT 0149929 AND NOTED WHAT APPEARS TO BE A FUNGAL BALL OF CONTAMINATION THAT WAS IN THE LIQUID SUPPLEMENT AND WAS TRANSFERRED TO THE PANTA WHEN RECONSTITUTING IT.

  Patient problems: No Patient Involvement

  MAUDE report 11282173 ↗